Otitis media is one of the most common childhood infections and the leading cause of visits to physicians in the pediatric population. Although most cases of otitis media are treated without diffi culty, up to 20% of children progress to persistent or recurrent acute otitis media or chronic otitis media. These conditions have presented major therapeutic challenges in the management of the disease. Furthermore, they may lead to many long-term complications, including irreversible middle ear disease, conductive and sensorineural hearing loss, impaired speech and language development, impaired academic achievement. A better understanding of the pathophysiology of the middle ear infl ammatory response during otitis media may direct us toward potential therapies for this disease.
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Hyperplasia of the middle ear mucosa is an important component of otitis media, involving substantial cell proliferation and differentiation. Hyperplasia contributes to the deleterious sequelae of otitis media, including the production of mucous secretions of middle ear effusions, fi brosis and other permanent damage that can occur in repeated and/or chronic otitis media. The regulation of mucosal hyperplasia in the middle ear is, therefore, of great clinical signifi cance.
The growth and differentiation of dividing cells are controlled in part by peptide growth factors, these endogenous, biologically active substances are constructed locally and released in a paracrine fashion at their site of action. There are only a few previous investigations that tested several growth factors that could be associated with the proliferation and differentiation of the middle ear mucosa during otitis media, such as Epidermal growth factor (EGF), Betacellulin, and keratinocyte growth factor (KGF), fibroblast growth factors 1 and 2 (FGF 1 and FGF 2). Furthermore there is no study that investigated this matter comprehensively.
Following these data, in this study, we explored other growth factors that are modulated during bacterial otitis media and may regulate mucosal hyperplasia of middle ear in a comprehensive manner.
Expression of selected genes involved in mucosal growth was evaluated by whole-genome DNA microarray techneque. Mice middle ear mucosae were harvested at several time points from 3 hour to 7 days after inoculation of H. infl uenzae or saline and analyzed. We identified 7 factors that their mRNA were highly expressed at early point after bacterial inoculation, along with the development of mucosal hyperplasia; Amphiregulin, Epiregulin, HB-EGF (heparin-binding epidermal growth factor), Cxcl-1, GDF-15, Activin A, LIF. To test their ability to infl uence mucosal hyperplasia, we used in vitro mucosal explant model. We cultured mucosal explant from rat middle ear mucosa and add recombinant growth factors into the culture media at several different concentrations (1-100 ng/ml). We measured the area of mucosal explants at day 10. Of those seven growth factors, HB-EGF had stimulatory effect on growth of middle ear mucosal explants. In the future, the mechanisms by which HB-EGF stimulate mucosal hyperplasia will be investigated further.
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